PCMA Welcomes Additions to Regulatory Affairs, Research Teams
January 15, 2021
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) is announcing two new additions to its Regulatory Affairs and Research teams. Debjani...
Filter by:
Choose a Topic
Filter by Year:Clear Filters- Press Releases
- Biosimilars
- Drug Abuse Prevention
- Drug Adherence Programs
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Employers, Unions, & Insurers
- FEHBP Program
- Formulary Design
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Health Insurance Marketplace (ACA)
- Home Delivery of Drugs
- Mark Merritt
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- REMS Management
- Specialty Benefit Design
- Specialty Pharmacies
- Specialty Pharmacy Networks
- TRICARE
- Value & Outcomes-Based Contracting
PCMA Statement on Senate Finance Committee Insulin Report
January 14, 2021
(Washington, D.C.) – The Pharmaceutical Care Management Association (PCMA) released the following statement on the Senate Finance Committee’s report on...
PCMA Federal Policy Priorities: 21 Policies to Reduce Prescription Drug Costs in 2021
January 14, 2021
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today issued 21 policy solutions supported by America’s pharmacy benefit managers (PBMs) aimed at reducing prescription...
PCMA Files Lawsuit Challenging Rebate Rule
January 12, 2021
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today filed a lawsuit challenging the Trump Administration’s rebate rule. PCMA’s...
New Research: Drug Manufacturers Undermine Rx Cost Savings Tools, Increase Drug Costs
January 07, 2021
(Washington, D.C.) — A new white paper, “Solving America’s High Drug Cost Problem: Prevent Drug Company Tactics that Increase Costs...